Ironwood Pharmaceuticals ...

NASDAQ: IRWD · Real-Time Price · USD
1.07
-0.02 (-1.83%)
At close: Aug 14, 2025, 3:59 PM
1.07
-0.47%
Pre-market: Aug 15, 2025, 06:32 AM EDT

Ironwood Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
88.56M 92.15M 656.2M 620.13M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 15.07M 24.48M
Other Long-Term Assets
5.92M 3.61M 847K 25.48M
Receivables
81.89M 129.12M 115.46M 114.04M
Inventory
n/a n/a 1.25M n/a
Other Current Assets
11.92M n/a n/a 2.37M
Total Current Assets
182.37M 233.29M 780.63M 745.23M
Property-Plant & Equipment
15.52M 18.17M 20.31M 22.93M
Goodwill & Intangibles
2.86M 3.68M n/a -24.48M
Total Long-Term Assets
168.54M 237.78M 319.89M 381.7M
Total Assets
350.91M 471.07M 1.1B 1.13B
Account Payables
2.13M 7.83M 483K 935K
Deferred Revenue
2.03M 2.62M n/a n/a
Short-Term Debt
n/a 199.56M n/a 116.86M
Other Current Liabilities
4.98M 26.13M 15.88M 7.49M
Total Current Liabilities
38.85M 276.1M 25.52M 161.7M
Long-Term Debt
583.99M 498.31M 396.25M 337.33M
Other Long-Term Liabilities
17.11M 28.41M 9.77M 3.5M
Total Long-Term Liabilities
613.4M 541.27M 422.62M 359.32M
Total Liabilities
652.24M 817.37M 448.14M 521.02M
Total Debt
599.48M 715.54M 415.92M 475.8M
Common Stock
160K 156K 154K 162K
Retained Earnings
-1.7B -1.7B -696.38M -937.61M
Comprehensive Income
923K -3.03M n/a n/a
Shareholders Equity
-301.33M -346.3M 652.38M 605.91M
Total Investments
n/a n/a 15.07M 24.48M